lutein + zeaxanthin

lutein + zeaxanthin is evaluated for the following indications with varying evidence strength: Age-related macular degeneration (evidence tier B), Cataract prevention (evidence tier D), Digital eye strain (computer vision syndrome) (evidence tier F). See the full indication matrix with dosing and citations above on this page.

Common side effects of lutein + zeaxanthin (≥ 1 in 100): Side effects at standard doses are rare. See the Safety section for uncommon and serious reactions.

FDA category C. Pregnancy data are insufficient. Lutein and zeaxanthin from dietary sources are safe. Supplement use in pregnancy is not recommended without clinical indication.

Transfers into breast milk. The effect of maternal supplementation on the infant has not been studied.

lutein + zeaxanthin is contraindicated in: Hypersensitivity to components; Pregnancy and breastfeeding (insufficient data). Full list in the Safety section.

an effect on digital eye strain is not confirmed in RCTs. In people without AMD, prophylactic use has no proven benefit.

the effect is slowing AMD progression, not improving acuity. In patients without retinal pathology, there is no effect on vision.

AREDS2 showed an effect only as part of the complete formula (lutein + zeaxanthin + vitamins C, E + zinc + copper). Isolated lutein without accompanying components has not confirmed clinical benefit in AMD.